Cetera Investment Advisers

Position in VKTX — Viking Therapeutics, Inc.

CIK 1666741 SCHAUMBURG, IL

Position in VKTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$6,150,971

-$520,423 QoQ

Shares Held

189,028

-0.3% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cetera Investment Advisers holds $158,169,500 across 104 Biotechnology names. VKTX ranks #7 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	72,633	$32,433,539
2	REGN	Regeneron Pharmaceuticals, Inc.	16,006	$12,366,875
3	ALNY	Alnylam Pharmaceuticals, Inc.	23,173	$7,667,250
4	EXEL	Exelixis, Inc.	169,881	$7,286,196
5	IBRX	ImmunityBio, Inc.	946,709	$7,261,258
6	OCUL	Ocular Therapeutix, Inc	764,615	$6,476,289
7	VKTX	Viking Therapeutics, Inc. This page	189,028	$6,150,971
8	INSM	INSMED Inc	34,356	$5,617,893

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,150,971	189,028	-0.3%	Shares	Sole	2026-05-13
2025-12-31	$6,671,394	189,636	+0.6%	Shares	Sole	2026-02-17
2025-09-30	$4,953,017	188,471	+19.6%	Shares	Sole	2025-11-14
2025-06-30	$4,177,407	157,638	+9.2%	Shares	Sole	2025-08-08
2025-03-31	$3,486,028	144,349	+67.5%	Shares	Sole	2025-05-06
2024-12-31	$3,467,923	86,181	+7.0%	Shares	Sole	2025-02-14
2024-09-30	$5,099,430	80,547	+63.3%	Shares	Sole	2024-11-13
2024-06-30	$2,613,976	49,311	+114.0%	Shares	Sole	2024-08-22
2024-03-31	$1,889,362	23,041	—	Shares	Sole	2024-05-24
No filing history on record for this holder in this stock.